Scientists at the University Medical Center Mainz have taken a further step towards improving our understanding of how asthma develops. These new findings show that the gene-regulating molecule "IRF4" plays a key role in the development of T helper 9 cells , which can play a major part in the development of this chronic, inflammatory illness of the respiratory tract.
The findings were proven for the first time in research carried out by the work group led by Dr. Tobias Bopp and Professor Dr. Edgar Schmitt from the Institute for Immunology, which was recently published in the internationally renowned journal "Immunity".
Over the past 100 years, asthma has developed from a relatively rare lung disease into an epidemic. Around 300 million people suffer from asthma worldwide. Between five and ten percent of the German population suffer from asthma. And twice as many men suffer from the illness than women. We know that allergic immune reactions can contribute significantly to the development of asthma. Hyperreactive Th cells, which form part of the body's own immune system, play a major role in the manifestation of this illness.
Different T cells carry out various tasks in the body's immune defense: Cells with a helper function known as T helper (Th) cells produce various cytokines that enable the different immune defense cells to communicate with each other, which in turn helps them launch a coordinated attack on pathogens or even tumour cells. However, if these cells react disproportionately to harmless substances, they can also cause disease. T helper cells can be divided into several sub-groups, including Th9 cells. These Th9 cells were characterized in two phases: They were described for the first time in 1994 as interleukin (IL)-9-producing T helper cells by Professor Schmitt, and finally became known as Th9 cells in 2008.
"Until now, only evidence was provided for the existence of Th9 cells and the crucial importance of IL-9 in the pathogenesis of asthma. However, as other cells beside T cells can produce IL-9 the major source of this cytokine was far from being definitive. To enable targeted therapeutic intervention, however, it was necessary to uncover the basic molecular mechanism underlying the development and function of IL-9-producing Th9 cells. Our analyses finally showed that IRF4 – a molecule that plays a key role in the regulation of genes – is essential for the development and function of Th9 cells," explain Dr. Tobias Bopp and Professor Dr. Edgar Schmitt from the Institute for Immunology.
The functional studies were carried out mainly on mice. The starting point was the observation that T cells in mice missing an intact IRF4 molecule do not develop into Th9 cells and are therefore unable to produce significant quantities of IL-9. As IL-9 is responsible for a variety of different asthma symptoms, the scientists led by Dr. Tobias Bopp and Professor Dr. Edgar Schmitt investigated to what extent IRF4 and consequently Th9 cells contribute to development and manifestation of asthma. These experiments showed that a failure in Th9 development prevents IRF4-deficient mice from asthma. Transfer of Th9 cells led to reappearance of asthma symptoms in such mice confirming the importance of this Th-subpopulation for the induction of asthma.
Professor Dr. Hansjörg Schild, Director of the Institute for Immunology, stresses how important basic research is for the development of new therapeutic strategies: "Asthma has been on the increase for decades in industrial countries. The discovery of Dr. Tobias Bopp and Professor Dr. Edgar Schmitt could provide the first step to improve existing therapeutic treatments but we still have a long and arduous journey ahead." The next step of the research process is to screen substances, among them naturally occurring molecules/agents, that suppress the production of IL-9 to develop innovative approaches for the treatment of asthma.
This view is also shared by Scientific Director of the University Medical Center Mainz, Professor Dr. Dr. Reinhard Urban: "Immunological illnesses are playing an ever greater role in our society. It is therefore only logical that the researchers in the University Medical Center should focus on the basic cellular mechanisms and use their results to help improve treatment for patients."Original publication:
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy